Indegene Stock Screener | Share Price & Fundamental Analysis

INDGN Healthcare Technology
Screen Indegene share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹522.60
▲ 1.85 (0.36%)
2026-01-06 00:00:00
Share Price BSE
₹522.05
▲ 1.30 (0.25%)
2026-01-06 00:00:00
Market Cap ₹12,504.07 Cr.
P/B Ratio 4.38
EPS (TTM) ₹17.15
Dividend Yield 0.38%
Debt to Equity 0.15
52W High ₹673.75
52W Low ₹503.95
Operating Margin 20.00%
Profit Margin 15.11%
Revenue (TTM) ₹781.00
EBITDA ₹173.00
Net Income ₹118.00
Total Assets ₹3,326.00
Total Equity ₹2,616.00

Indegene Share Price History - Stock Screener Chart

Screen INDGN historical share price movements with interactive charts. Analyze price trends and patterns.

Indegene Company Profile - Fundamental Screener

Screen Indegene company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDGN shares.
Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions, and Others. These segments assist with digital marketing operations, last-mile promotion optimization, regulatory and medical operations consolidation, and clinical solutions and consultancy services. The company has made several acquisitions to expand its capabilities, including Encima Group, DT Associates, Cult Health, and Trilogy Writing & Consulting GmbH. In 2023, Indegene launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform. The company completed a public issue in May 2024, raising funds through a fresh issue and offer for sale.
Sector Healthcare
Industry Healthcare Technology
Sub-Sector Healthcare Technology
Segment E
Chairperson/CEO Manish Gupta
ISIN INE065X01017

Indegene Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen INDGN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019
Assets
Total Assets 3,326 2,546 2,204 1,354 596 600 329
Current Assets 2,530 1,791 1,449 1,130 459 418 185
Fixed Assets 678 646 664 138 86 119 104
Liabilities
Total Liabilities 3,326 2,546 2,204 1,354 596 600 329
Current Liabilities 146 506 651 149 64 369 18
Non-Current Liabilities 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 2,616 1,429 1,064 764 333 -16 152
Share Capital 48 44 44 0 0 0 79
Reserves & Surplus 2,567 1,385 1,020 764 324 -105 73
Screen INDGN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Jun
Revenue 781 783 824 699 699 708 758 645 636 647 687 540
Expenses 608 606 664 534 548 561 589 535 511 515 525 413
EBITDA 173 177 160 164 151 148 170 111 125 133 162 127
Operating Profit % 20.00% 20.00% 17.00% 21.00% 19.00% 18.00% 18.00% 15.00% 16.00% 19.00% 22.00% 21.00%
Depreciation 21 22 23 19 20 19 20 20 20 20 18 10
Interest 3 4 4 12 12 4 3 12 13 12 12 2
Profit Before Tax 149 152 133 134 120 124 146 79 93 101 132 115
Tax 32 36 31 39 32 32 37 30 24 26 34 29
Net Profit 118 116 102 95 88 92 110 49 68 75 99 86
EPS 4.91 4.86 4.26 4.27 3.79 3.84 4.59 2.20 3.09 3.38 4.45 3.88

Indegene Cash Flow Screener - Liquidity Fundamentals

Screen INDGN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March
Operating Activities 442 508 130 297 172 22 65
Investing Activities -677 -327 -896 -158 -81 -16 -18
Financing Activities 288 -66 333 234 -132 136 -21
Net Cash Flow 52 115 -433 373 -41 143 25
Screen INDGN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-May 2024-Apr
Promoter Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
FII Holding 11.30% 10.05% 5.24% 5.03% 4.82% 3.79% 0.00% 0.00%
DII Holding 6.96% 7.20% 4.96% 3.98% 3.17% 3.84% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 13.28% 13.51% 11.34% 26.41% 24.32% 24.67% 0.00% 0.00%
Other Holding 68.46% 69.24% 78.45% 64.58% 67.69% 67.70% 100.00% 100.00%
Shareholder Count 151,809 151,997 144,708 153,789 151,440 203,599 82 82

Indegene Dividend Screener - Share Yield Analysis

Screen INDGN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Period Dividend Per Share Dividend Yield
2025-March ₹2.00 0.38%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%
2016-March ₹0.00 0.00%

Indegene Index Membership - Market Screener Classification

Screen INDGN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.

Indegene Market Events Screener - Corporate Actions

Screen INDGN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 9.73%
2025-10-30 2025-10-30 Quarterly Result Announcement NA -1.67%
2025-07-31 2025-07-31 Quarterly Result Announcement NA -2.22%
2025-06-26 2025-06-26 Annual General Meeting NA -4.70%
2025-06-13 2025-06-13 Dividend ₹ 2.00 /share 5.49%
2025-04-28 2025-04-28 Quarterly Result Announcement NA -0.50%
2025-01-30 2025-01-30 Quarterly Result Announcement NA -6.18%
2024-10-28 2024-10-28 Quarterly Result Announcement NA 3.40%
2022-11-17 2022-11-17 Change Of Name NA -

Indegene Competitors Screener - Peer Comparison

Screen INDGN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Syngene International 25,939 56.30 3,714 3.77% 496 47.49
Indegene 12,504 28.17 2,947 10.53% 407 43.48
Suven Life Sciences 3,809 -17.51 18 -46.34% -161 43.11
Vimta Labs 2,658 43.83 322 0.22% 41 42.43
Take Solutions 586 11.76 10 126.67% 1 86.68
Bilcare 184 -4.18 807 4.78% -56 42.36
Jeevan Scientific Technology 103 -22.20 48 17.87% 0 67.46
Adeshwar Meditex 26 33.09 84 5.00% 2 21.98
Vanta Bioscience 16 -1.10 2 -78.57% -13 51.57

Indegene Company Announcements - News Screener

Screen INDGN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-01-06 Closure of Trading Window View
2025-12-31 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-12-30 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot View
2025-12-19 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS View
2025-12-19 Announcement under Regulation 30 (LODR)-Change in Directorate View
2025-11-26 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-14 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-10 Announcement under Regulation 30 (LODR)-Acquisition View
2025-11-03 Announcement under Regulation 30 (LODR)-Earnings Call Transcript View
2025-11-01 Intimation Of Opening Of Trading Window View
2025-11-01 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-10-31 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2025-10-31 Announcement under Regulation 30 (LODR)-Monitoring Agency Report View
2025-10-30 Disclosure Under SEBI (LODR) Regulations 2015 - Investment In Wholly Owned Subsidiary View
2025-10-30 Announcement under Regulation 30 (LODR)-Investor Presentation View
2025-10-30 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2025-10-30 Disclosure Under Regulation 30 Of SEBI(LODR) Regulations 2015 - Intimation Of Grant View
2025-10-30 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS View
2025-10-30 Outcome Of Board Meeting - Q2FY26 Results View